|
FAM190B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88880022733429E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.37470043629173E-11 |
| Normal-vs-Stage2 |
5.438000E-04 |
| Normal-vs-Stage3 |
6.46249999999293E-05 |
| Normal-vs-Stage4 |
1.70543999999939E-05 |
| Stage1-vs-Stage2 |
5.388400E-01 |
| Stage1-vs-Stage3 |
6.770400E-01 |
| Stage1-vs-Stage4 |
6.863600E-01 |
| Stage2-vs-Stage3 |
8.385000E-01 |
| Stage2-vs-Stage4 |
4.387000E-01 |
| Stage3-vs-Stage4 |
5.467600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.2941873935074E-12 |
| Normal-vs-AfricanAmerican |
1.35150000002415E-06 |
| Normal-vs-Asian |
2.239000E-03 |
| Caucasian-vs-AfricanAmerican |
2.421200E-01 |
| Caucasian-vs-Asian |
7.908200E-01 |
| AfricanAmerican-vs-Asian |
8.900000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81699100210153E-12 |
| Normal-vs-Female |
2.338200E-03 |
| Male-vs-Female |
2.178200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.48900000002317E-07 |
| Normal-vs-Extreme_Weight |
1.88526971811598E-12 |
| Normal-vs-Obese |
6.68420000016212E-07 |
| Normal-vs-Extreme_Obese |
2.067600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.491000E-01 |
| Normal_Weight-vs-Obese |
2.199200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.868000E-01 |
| Extreme_Weight-vs-Obese |
1.441530E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.885600E-01 |
| Obese-vs-Extreme_Obese |
7.672400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.363700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.99560004474375E-09 |
| Normal-vs-Age(61-80Yrs) |
1.38322686638048E-12 |
| Normal-vs-Age(81-100Yrs) |
2.95460000909742E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.223000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.696810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.750100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.439500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.525900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.610200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.70949929159769E-12 |
| Normal-VS-Type2 PRCC |
6.49289999543612E-09 |
| Normal-VS-KIRP CIMP |
1.072830E-01 |
| Normal-VS-Unclassified PRCC |
1.772400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.490800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.033900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.104630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.409700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.166800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.338800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62790011973379E-10 |
| Normal-vs-N1 |
7.89119999999865E-05 |
| Normal-vs-N2 |
5.976400E-04 |
| N0-vs-N1 |
2.036600E-01 |
| N0-vs-N2 |
9.923600E-01 |
| N1-vs-N2 |
5.324200E-01 |
|
|
